Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone In small first-line trial, PFS more than doubled with combination Jan 26, 2024
Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer OS, PFS, cancer-specific survival all improved, with no increase in toxicity Jan 26, 2024
Apalutamide Makes Its Case in Biochemically Recurrent Nonmetastatic Prostate Cancer Intensification should be considered for high-risk patients, researchers say Jan 24, 2024
Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancer News, features, and commentary about cancer-related issues Jan 19, 2024
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet But opening up can help reduce stigma and inform the public Jan 18, 2024
Surgeon Dies in Plane Crash; Austin Released From Hospital; Animal Pandemic Spreads Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Jan 16, 2024
Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA News, features, and commentary about cancer-related issues Jan 12, 2024
No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsy No effect on anxiety but significantly less patient-rated pain Jan 12, 2024
Trump-Era Conscience Rule Rescinded; Lloyd Austin's Cancer; Sinead O'Connor's Death Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Jan 10, 2024
More Evidence Linking ADT for Prostate Cancer to Adverse Neurocognitive Effects Meta-analysis shows increased risk of dementia, Parkinson's, depression Jan 09, 2024
Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras News, features, and commentary about cancer-related issues Jan 05, 2024
Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer News, features, and commentary about cancer-related issues Dec 28, 2023
Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Risk No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRC News, features, and commentary about cancer-related issues Dec 21, 2023
Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug News, features, and commentary about cancer-related issues Dec 07, 2023
TULSA Effective in Controlling Prostate Cancer Long-Term At 5 years, median PSA was reduced by 90% Dec 05, 2023
Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomy Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
Vitamin D for Neuropathy; Good & Bad News for CAR-T; New Labeling for Surgical Mesh News, features, and commentary about cancer-related issues Nov 10, 2023
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities A "local heroes effect" can better reach communities of color Nov 09, 2023
Wearables as Cancer Monitors; No China Price Break; Cancer Mystery in Appalachia News, features, and commentary about cancer-related issues Nov 03, 2023
Transitioning Cancer Survivors Away From Oncologic Care It's time for a new model of care Nov 03, 2023
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPC Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfers Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
Lonely Cancer Deaths; Virtual Reality for Pain; 3D Models May Improve Treatment News, features, and commentary about cancer-related issues Oct 19, 2023
Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train? It's time for clear guidelines Oct 18, 2023
Hair Relaxers' Cancer Risk; Genetic Test Aids Rural Care; Drug Negotiation Fallout? News, features, and commentary about cancer-related issues Oct 13, 2023
SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancer Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancer Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
TikTok Dinged for Misinformation; BRCA Risk Overestimated; Cheers for Oncology News, features, and commentary about cancer-related issues Sep 21, 2023
Cisplatin Shortage Eases; Air Pollution Linked to Breast Cancer; Pap Test Confusion News, features, and commentary about cancer-related issues Sep 15, 2023
Global Incidence of Early-Onset Cancer Has Surged Since 1990 Early-onset breast cancer has highest incidence and mortality rates Sep 06, 2023
Prostate Cancer Is Not Just an 'Old Man's Disease' Spreading this message can save lives Sep 02, 2023
Prayer to Cure Cancer; Exercise for Sexual Dysfunction; Carb Intake and Cancer News, features, and commentary about cancer-related issues Sep 01, 2023
Does Cancer Screening Actually Extend Lives? A series of articles look at whether the benefits for the few warrant the harms for the many Aug 28, 2023
Multi-Cancer Early Detection: 20th-Century Fiction Becomes Reality These tests could soon become a valuable addition to current cancer screening tools Aug 01, 2023
MR-Guided Adaptive SBRT Tied to Reduced Side Effects in Prostate Cancer However, this technique requires more time and resources than standard techniques Jul 24, 2023
Lumpers vs Splitters: Categorizing Prostate Cancer Should very low-risk and low-risk be combined into one? May 19, 2023
